Neurodegenerative Disease Management

eISSN: 1758-2032pISSN: 1758-2024

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
3.6
H-Index
29
SJR
Q2Neurology (clinical)
SNIP
0.59
5
Time to Publish
time-to-publish View Chart
6  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science
  • Scopus
  • SJR
Overview
  • Publisher
    FUTURE MEDICINE LTD
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 0%
4-6 46%
7-9 21%
>9 33%

Topics Covered

Multiple sclerosis
Cannabinoid
Cognitive impairment
Parkinson's disease
Physical performance
Alzheimer's disease
Mitoxantrone
Nutritional status
Secondary progressive multiple sclerosis
Goal Attainment Scaling
Cognitive screening
Huntington's disease
Chronic inflammatory demyelinating polyneuropathy
Expanded Disability Status Scale
Body mass index
Rivastigmine
Intravenous methylprednisolone
Deep brain stimulation
Tetrahydrocannabinol
Neutropenia

Recently Published Papers

Year-wise Publication

FAQs

Since when has Neurodegenerative Disease Management been publishing? Faqs

The Neurodegenerative Disease Management has been publishing since 2011 till date.

How frequently is the Neurodegenerative Disease Management published? Faqs

Neurodegenerative Disease Management is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Neurodegenerative Disease Management? Faqs

Neurodegenerative Disease Management has a H-index score of 29, Citescore of 3.6, SNIP score of 0.59, & SJR of Q2

Who is the publisher of Neurodegenerative Disease Management? Faqs

The publisher of Neurodegenerative Disease Management is FUTURE MEDICINE LTD.

How can I view the journal metrics of Neurodegenerative Disease Management on editage? Faqs

For the Neurodegenerative Disease Management metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Neurodegenerative Disease Management? Faqs

The eISSN number is 1758-2032 and pISSN number is 1758-2024 for Neurodegenerative Disease Management.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Multiple sclerosis, Cannabinoid, Cognitive impairment, Parkinson's disease, Physical performance, Alzheimer's disease, Mitoxantrone, Nutritional status, Secondary progressive multiple sclerosis, Goal Attainment Scaling, Cognitive screening, Huntington's disease, Chronic inflammatory demyelinating polyneuropathy, Expanded Disability Status Scale, Body mass index, Rivastigmine, Intravenous methylprednisolone, Deep brain stimulation, Tetrahydrocannabinol, Neutropenia.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.